AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31758571 — intervention group
Group type: COMPARATOR
Intervention: Concomitant therapy (14 days of rabeprazole, clarithromycin, amoxycillin, and tinidazole; 140 pills, cost US$23)
Number of subjects: 313
Study 31758571 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential therapy
Number of subjects: 313
Study 31758571 — intervention group
Group type: COMPARATOR
Intervention: Concomitant therapy
Number of subjects: 313
Study 29665833 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioactive vitamin D (calcitriol) added to RAAS inhibition treatment using ACEI or ARB
Number of subjects: 320
Study 28498184 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care
Number of subjects: 1269
Study 28498184 — intervention group
Group type: COMPARATOR
Intervention: Facility Peer Support
Number of subjects: 1269
Study 28498184 — intervention group
Group type: COMPARATOR
Intervention: Community Peer Support
Number of subjects: 1269
Study 28498184 — intervention group
Group type: EXPERIMENTAL
Intervention: ART failure (HIVRNA ≥1000 copies/ml)
Number of subjects: 1269
Study 25748549 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise programme (six sessions of strengthening and stretching exercises with a hand therapist, daily home exercises)
Number of subjects: 490
Study 25748549 — intervention group
Group type: COMPARATOR
Intervention: Usual care (joint protection education, general exercise advice, functional splinting if required)
Number of subjects: 490
Study 25748549 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise programme
Number of subjects: 490
Study 23032305 — intervention group
Group type: EXPERIMENTAL
Intervention: Caloric restriction + resistance training (CRRT)
Number of subjects: 127
Study 23032305 — intervention group
Group type: COMPARATOR
Intervention: Caloric restriction (CR)
Number of subjects: 127
Study 20204491 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation counseling delivered by nurses
Number of subjects: 273
Study 18067975 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication (tianeptine or fluoxetine) + Psychotherapy (supportive, cognitive-behavioral, or psychodynamic)
Number of subjects: 649
Study 16758107 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional standing postero-anterior full spine radiograph (n=53)
Number of subjects: 150
Study 16758107 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital storage phosphor plate system (CR) (n=48)
Number of subjects: 150
Study 16758107 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital pulsed fluoroscopy (n=49)
Number of subjects: 150
Study 16758107 — intervention group
Group type: COMPARATOR
Intervention: Conventional films (control group)
Number of subjects: 150
Study 12676739 — intervention group
Group type: COMPARATOR
Intervention: Furosemide (40 mg, orally) with placebo
Number of subjects: 10
Study 12676739 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide (40 mg, orally) with losartan (50 mg, orally)
Number of subjects: 10
Study 11099170 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise test after 24 hours recovery
Number of subjects: 48
Study 11099170 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise test after 48 hours recovery
Number of subjects: 48
Study 11099170 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise test after 72 hours recovery
Number of subjects: 48
Study 11099170 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise test after 96 hours recovery
Number of subjects: 48
Study 8831526 — intervention group
Group type: EXPERIMENTAL
Intervention: Transanal endoscopic microsurgery (TEM)
Number of subjects: 42
Study 1506604 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 g glucose ingestion in late pregnant women
Number of subjects: 45
Study 1506604 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 g glucose ingestion in nonpregnant women
Number of subjects: 45
Study 1506604 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 g glucose ingestion in early pregnant women
Number of subjects: 45
Study 4047384 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (Inderal)
Number of subjects: 14
Study 4047384 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (Tenormin)
Number of subjects: 14
Study 4047384 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 30506745 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation (5 g micronized creatine monohydrate daily for three weeks; n=31)
Number of subjects: 49
Study 30506745 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=18)
Number of subjects: 49
Study 30140739 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute sleep loss
Number of subjects: 0
Study 30140739 — intervention group
Group type: COMPARATOR
Intervention: One full night of sleep
Number of subjects: 0
Study 26989892 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg arhalofenate
Number of subjects: 239
Study 26989892 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg arhalofenate
Number of subjects: 239
Study 26989892 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 239
Study 26989892 — intervention group
Group type: COMPARATOR
Intervention: 300 mg allopurinol
Number of subjects: 239
Study 24901666 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking intervention
Number of subjects: 37
Study 24901666 — intervention group
Group type: COMPARATOR
Intervention: Non‐intervention control
Number of subjects: 37
Study 22908679 — intervention group
Group type: EXPERIMENTAL
Intervention: Happy mood with time pressure
Number of subjects: 6
Study 22908679 — intervention group
Group type: EXPERIMENTAL
Intervention: Sad mood with time pressure
Number of subjects: 6
Study 22908679 — intervention group
Group type: EXPERIMENTAL
Intervention: Happy mood without time pressure
Number of subjects: 6
Study 22908679 — intervention group
Group type: EXPERIMENTAL
Intervention: Sad mood without time pressure
Number of subjects: 6
Study 22908679 — intervention group
Group type: EXPERIMENTAL
Intervention: Time pressure present
Number of subjects: 6
Study 22908679 — intervention group
Group type: COMPARATOR
Intervention: Time pressure absent
Number of subjects: 6
Study 19019470 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 50 mg/day
Number of subjects: 69
Study 19019470 — intervention group
Group type: COMPARATOR
Intervention: Control group (no atenolol)
Number of subjects: 69
Study 18045815 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine (20 mg x kg(‐1))
Number of subjects: 19
Study 18045815 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 16007562 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional intervention with Oxepa and Nepro (one can of each during each hemodialysis session for 4 weeks)
Number of subjects: 21
Study 16007562 — intervention group
Group type: COMPARATOR
Intervention: Control group (20 patients not receiving nutritional intervention)
Number of subjects: 21
Study 11876241 — intervention group
Group type: EXPERIMENTAL
Intervention: Segmental bioimpedance spectroscopy
Number of subjects: 100
Study 11876241 — intervention group
Group type: COMPARATOR
Intervention: Global bioimpedance spectroscopy
Number of subjects: 100
Study 10454944 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational strategy promoting six recommendations for evaluation and management of dementia, including a mailed American Academy of Neurology continuing medical education course, practice-based tools, an interactive seminar led by local opinion leaders, and follow-up mailings.
Number of subjects: 417
Study 10454944 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational strategy promoting six recommendations for evaluation and management of dementia.
Number of subjects: 417
Study 10454944 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-intervention).
Number of subjects: 417
Study 7832339 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced-air warming
Number of subjects: 74
Study 7832339 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 74
Study 7832339 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 74
Study 2700179 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketac‐Bond
Number of subjects: 90
Study 2700179 — intervention group
Group type: EXPERIMENTAL
Intervention: Shofu Glasionomer Base Cement
Number of subjects: 90
Study 2700179 — intervention group
Group type: COMPARATOR
Intervention: Chemomechanical technique
Number of subjects: 90
Study 2700179 — intervention group
Group type: COMPARATOR
Intervention: Conventional mechanical drilling
Number of subjects: 90
Study 26372 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous phentolamine
Number of subjects: 0
Study 30681802 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceramide containing cleanser and cream with salicylic acid, used twice daily for 28 days.
Number of subjects: 35
Study 30571205 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcarotid TAVR
Number of subjects: 329
Study 27399136 — intervention group
Group type: EXPERIMENTAL
Intervention: AA combined with infrahepatic IVC clamping (group A)
Number of subjects: 101
Study 27399136 — intervention group
Group type: COMPARATOR
Intervention: AA alone (group B)
Number of subjects: 101
Study 23911139 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure near the steel plant
Number of subjects: 61
Study 23911139 — intervention group
Group type: COMPARATOR
Intervention: Exposure at the college site
Number of subjects: 61
Study 23911139 — intervention group
Group type: EXPERIMENTAL
Intervention: Interquartile range concentrations of SO2 (2.9 ppb)
Number of subjects: 61
Study 23911139 — intervention group
Group type: EXPERIMENTAL
Intervention: Interquartile range concentrations of NO2 (5.0 ppb)
Number of subjects: 61
Study 23911139 — intervention group
Group type: EXPERIMENTAL
Intervention: Interquartile range concentrations of CO (0.2 ppm)
Number of subjects: 61
Study 23911139 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrafine particles (10,256 count/cm(3))
Number of subjects: 61
Study 22402975 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative nerve monitoring (IONM)
Number of subjects: 210
Study 22402975 — intervention group
Group type: COMPARATOR
Intervention: Visual inspection of the EBSLN and RLN
Number of subjects: 210
Study 18671798 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine and weight management
Number of subjects: 10742
Study 17632223 — intervention group
Group type: EXPERIMENTAL
Intervention: bupropion SR 300 mg/d + high-dose dual nicotine replacement therapy (NRT) + weekly group cognitive behavioral therapy (CBT)
Number of subjects: 51
Study 17632223 — intervention group
Group type: COMPARATOR
Intervention: placebo + high-dose dual nicotine replacement therapy (NRT) + weekly group cognitive behavioral therapy (CBT)
Number of subjects: 51
Study 15188360 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental intervention (1-hour session with a nurse educator + monthly telephone counseling for 6 months)
Number of subjects: 122
Study 15188360 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental intervention
Number of subjects: 122
Study 15188360 — intervention group
Group type: COMPARATOR
Intervention: Control group (attention placebo: 45-minute video presentation about lupus + monthly telephone calls)
Number of subjects: 122
Study 11457745 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan (n=30)
Number of subjects: 60
Study 11457745 — intervention group
Group type: COMPARATOR
Intervention: Calcium antagonists (nifedipine or manidipine) (n=30)
Number of subjects: 60
Study 10193320 — intervention group
Group type: EXPERIMENTAL
Intervention: Nested PCR
Number of subjects: 0
Study 10193320 — intervention group
Group type: EXPERIMENTAL
Intervention: In situ hybridisation
Number of subjects: 0
Study 10193320 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunocytochemistry
Number of subjects: 0
Study 10193320 — intervention group
Group type: EXPERIMENTAL
Intervention: Hematoxylin and eosin (H&E)
Number of subjects: 0
Study 10193320 — intervention group
Group type: COMPARATOR
Intervention: H&E and immunocytochemistry
Number of subjects: 0
Study 10193320 — intervention group
Group type: EXPERIMENTAL
Intervention: Nested PCR after negative H&E and immunocytochemistry
Number of subjects: 0
Study 7822113 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychiatric labels (specific labels applied to vignettes)
Number of subjects: 84
Study 7822113 — intervention group
Group type: EXPERIMENTAL
Intervention: Types of psychopathology (with and without labels)
Number of subjects: 84
Study 3284316 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous sotalol (1.5 mg/kg load followed by 0.008 mg/kg maintenance, mean dose 150 +/‐ 23 mg)
Number of subjects: 16
Study 3284316 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sotalol (mean dose 583 +/‐ 204 mg daily)
Number of subjects: 16
Study 30676124 — intervention group
Group type: EXPERIMENTAL
Intervention: VAS-Version of the Working Alliance Inventory (WAI)‐Rehabilitation Dutch Version
Number of subjects: 176
Study 30676124 — intervention group
Group type: COMPARATOR
Intervention: Original Version of the Working Alliance Inventory (WAI)‐Rehabilitation Dutch Version
Number of subjects: 176
Study 30676124 — intervention group
Group type: COMPARATOR
Intervention: Positive-Packed Version of the Working Alliance Inventory (WAI)‐Rehabilitation Dutch Version
Number of subjects: 176
Study 28799712 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferred stent implantation
Number of subjects: 1570
Study 27352488 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep acupuncture at Lianquan (CV 23) and Yifeng (TE 17) combined with swallowing training (twice a day, 20 min per treatment)
Number of subjects: 60
Study 27352488 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep acupuncture at Lianquan (CV 23) and Yifeng (TE 17) combined with swallowing training
Number of subjects: 60
Study 27352488 — intervention group
Group type: COMPARATOR
Intervention: Swallowing training
Number of subjects: 60
Study 25243955 — intervention group
Group type: EXPERIMENTAL
Intervention: Telbivudine (LdT) 600 mg once daily
Number of subjects: 118
Study 25243955 — intervention group
Group type: COMPARATOR
Intervention: Control (no LdT treatment)
Number of subjects: 118
Study 22895585 — intervention group
Group type: EXPERIMENTAL
Intervention: HD-MTX-based chemotherapy
Number of subjects: 126
Study 22895585 — intervention group
Group type: EXPERIMENTAL
Intervention: Salvage whole brain radiotherapy
Number of subjects: 126
Study 20388472 — intervention group
Group type: EXPERIMENTAL
Intervention: Qingshen Granule (1 dosage each time, 3 times a day for one month)
Number of subjects: 60
Study 20388472 — intervention group
Group type: COMPARATOR
Intervention: Jiedu Xiezhuo II (retention enema for both groups)
Number of subjects: 60
Study 18042503 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir DF (TDF) + Lamivudine (3TC) + Efavirenz (EFV)
Number of subjects: 85
Study 15630062 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental support intervention (ES)
Number of subjects: 181
Study 15630062 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 181
Study 11850136 — intervention group
Group type: EXPERIMENTAL
Intervention: Classroom‐centered (CC) intervention
Number of subjects: 678
Study 11850136 — intervention group
Group type: EXPERIMENTAL
Intervention: Family‐school partnership (FSP) intervention
Number of subjects: 678
Study 11850136 — intervention group
Group type: COMPARATOR
Intervention: Control classroom
Number of subjects: 678
Study 9012303 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative forced-air warming via an upper-body blanket (Warm Touch, Mallinckrodt, USA)
Number of subjects: 24
Study 9012303 — intervention group
Group type: COMPARATOR
Intervention: Conventional patient insulation with cotton blankets (control group)
Number of subjects: 24
Study 9012303 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative forced-air warming
Number of subjects: 24
Study 9012303 — intervention group
Group type: COMPARATOR
Intervention: Control group (no warming therapy)
Number of subjects: 24
Study 2290141 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperventilation provocation test (HVPT)
Number of subjects: 23
Study 2290141 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental load task (Stroop Color Word Test; CWT)
Number of subjects: 23
Study 2290141 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological state and trait measures (SCL-90 and STAI scores)
Number of subjects: 23
Study 2290141 — intervention group
Group type: EXPERIMENTAL
Intervention: Degree of hypocapnia
Number of subjects: 23
Study 386388 — intervention group
Group type: EXPERIMENTAL
Intervention: Racemic propranolol (high doses)
Number of subjects: 12
Study 386388 — intervention group
Group type: COMPARATOR
Intervention: d-propranolol (d-stereoisomer, practically devoid of beta-blocking activity)
Number of subjects: 12
Study 31480866 — intervention group
Group type: EXPERIMENTAL
Intervention: Narratives reporting Vaccine Adverse Events (VAE) at 35% frequency
Number of subjects: 564
Study 31480866 — intervention group
Group type: EXPERIMENTAL
Intervention: Narratives reporting Vaccine Adverse Events (VAE) at 5% frequency
Number of subjects: 564
Study 31480866 — intervention group
Group type: COMPARATOR
Intervention: Control condition with 20% frequency of VAE narratives
Number of subjects: 564
Study 31291738 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational nutritional intervention (individual, collective, and telephone interventions)
Number of subjects: 75
Study 31291738 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational nutritional intervention
Number of subjects: 75
Study 31291738 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 75
Study 28647064 — intervention group
Group type: EXPERIMENTAL
Intervention: doktormitSDM training module (two video-based individual coaching sessions of 15 minutes each)
Number of subjects: 152
Study 28647064 — intervention group
Group type: EXPERIMENTAL
Intervention: doktormitSDM training module
Number of subjects: 152
Study 26002878 — intervention group
Group type: EXPERIMENTAL
Intervention: IDAP Treatment Program
Number of subjects: 340
Study 26002878 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 340
Study 23343704 — intervention group
Group type: EXPERIMENTAL
Intervention: palmitoylethanolamide (PEA) 400 mg and transpolydatin 40 mg
Number of subjects: 20
Study 23343704 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study 21161174 — intervention group
Group type: EXPERIMENTAL
Intervention: Cement Group
Number of subjects: 130
Study 21161174 — intervention group
Group type: COMPARATOR
Intervention: Hybrid Group
Number of subjects: 130
Study 19625064 — intervention group
Group type: EXPERIMENTAL
Intervention: High n-3 OFTT (2:1 n-6/n-3 PUFA ratio)
Number of subjects: 8
Study 19625064 — intervention group
Group type: EXPERIMENTAL
Intervention: Low n-3 OFTT (20:1 n-6/n-3 PUFA ratio)
Number of subjects: 8
Study 19625064 — intervention group
Group type: COMPARATOR
Intervention: Water control
Number of subjects: 8
Study 17445927 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin (6 mg/m2 i.v. x20, daily before RT) with RT (35 x 2 Gy)
Number of subjects: 121
Study 17445927 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydr‐Ac‐RT Group (daily i.v. prehydration and accelerated RT)
Number of subjects: 121
Study 17445927 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydr‐Ac‐RT Group
Number of subjects: 121
Study 17445927 — intervention group
Group type: COMPARATOR
Intervention: Standard Group
Number of subjects: 121
Study 15491034 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% dorzolamide hydrochloride eyedrops
Number of subjects: 17
Study 15491034 — intervention group
Group type: COMPARATOR
Intervention: Placebo (artificial tears)
Number of subjects: 17
Study 11133796 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with intractable mesial temporal lobe epilepsy
Number of subjects: 62
Study 11133796 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 62
Study 9704545 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative erectile impairment in sexually active patients (n=104)
Number of subjects: 253
Study 9704545 — intervention group
Group type: EXPERIMENTAL
Intervention: Total erectile failure
Number of subjects: 253
Study 9704545 — intervention group
Group type: EXPERIMENTAL
Intervention: Retention of ejaculation after TURP
Number of subjects: 253
Study 9704545 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors for post-operative erectile failure
Number of subjects: 253
Study 9704545 — intervention group
Group type: EXPERIMENTAL
Intervention: Incidence of erectile failure after TURP
Number of subjects: 253
Study 9704545 — intervention group
Group type: EXPERIMENTAL
Intervention: Incidence of ejaculatory failure
Number of subjects: 253
Study 8524718 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally appropriate intervention to increase breast and cervical cancer screening practices
Number of subjects: 1260
Study 2568792 — intervention group
Group type: EXPERIMENTAL
Intervention: Iotrolan (new contrast medium)
Number of subjects: 0
Study 2568792 — intervention group
Group type: COMPARATOR
Intervention: Ionic monomeric preparation
Number of subjects: 0
Study 2568792 — intervention group
Group type: COMPARATOR
Intervention: Nonionic monomeric preparation
Number of subjects: 0
Study 1014119 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose medroxyprogesterone
Number of subjects: 20
Study 1014119 — intervention group
Group type: COMPARATOR
Intervention: Alcohol infusion of the pituitary
Number of subjects: 20
Study 30949660 — intervention group
Group type: EXPERIMENTAL
Intervention: Redesigned menu with fruit and vegetable snacks positioned first and last
Number of subjects: 1938
Study 30949660 — intervention group
Group type: COMPARATOR
Intervention: Control group with no change to the online menu
Number of subjects: 1938
Study 28916534 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproic acid
Number of subjects: 382
Study 28916534 — intervention group
Group type: COMPARATOR
Intervention: Ethosuximide
Number of subjects: 382
Study 25499037 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial alternating current stimulation with extracephalic return contralateral to the primary stimulating electrode
Number of subjects: 12
Study 25499037 — intervention group
Group type: EXPERIMENTAL
Intervention: Photic stimulation
Number of subjects: 12
Study 25499037 — intervention group
Group type: COMPARATOR
Intervention: Fronto-orbital montage
Number of subjects: 12
Study 23706959 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive RBC transfusion policy (hemoglobin <8 g/dL)
Number of subjects: 0
Study 23706959 — intervention group
Group type: COMPARATOR
Intervention: Liberal RBC transfusion policy (hemoglobin <10 g/dL)
Number of subjects: 0